Luciferase: A sensitive and quantitative probe for blood-brain barrier disruption

Journal of Neuroscience Methods

Volumn 83, Issue 2, 1998, Pages 159-164

  Deng, Sophie X ^a   Panahian, Nariman ^a   James, Harold ^a   Gelbard, Harris A ^a   Federoff, Howard J ^a   Dewhurst, Stephen ^a   Epstein, Leon G ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Blood brain barrier; Luciferase; Mannitol

Indexed keywords

LUCIFERASE; MANNITOL; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; ENZYME ASSAY; IMMUNOHISTOCHEMISTRY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES; BLOOD-BRAIN BARRIER; BRAIN CHEMISTRY; DIURETICS, OSMOTIC; IMMUNOHISTOCHEMISTRY; LIVER; LUCIFERASES; MALE; MANNITOL; MICE; MICE, INBRED BALB C;

EID: 0032167559     PISSN: 01650270     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-0270(98)00077-6     Document Type: Article

References (28)

1. Brightman M.W., Ishihara S., Chang L. Penetration of solutes, viruses, and cells across the blood-brain barrier. Curr Top Microbiol Immunol. 202:1995;63-78.
2. Claudio L. Ultrastructural features of the blood-brain barrier in biopsy tissue from Alzheimer's disease patients. Acta Neuropathol. 91:1996;6-14.
3. Claudio L., Raine C.S., Brosnan C.F. Evidence of persistent blood-brain barrier abnormalities in chronic-progressive multiple sclerosis. Acta Neuropathol. 90:1995;228-238.
4. Cosolo W.C., Martinello P., Louis W.J., Christophidis N. Blood-brain barrier disruption using mannitol: time course and electron microscopy studies. Am J Physiol. 256:1989;R443-447.
5. de Wet J.R., Wood K.V., DeLuca M., Helinski D.R., Subramani S. Firefly luciferase gene: structure and expression in mammalian cells. Mol Cell Biol. 7:1987;725-737.
6. Dollard S.C., Gummuluru S., Tsang S., Fultz P.N., Dewhurst S. Enhanced responsiveness to nuclear factor kappa B contributes to the unique phenotype of simian immunodeficiency virus variant SIVsmmPBj14. J Virol. 68:1994;7800-7809.
7. Dollard S.C., James H.J., Sharer L.R., Epstein L.G., Gelbard H.A., Dewhurst S. Activation of nuclear factor kappa-B in brains from children with HIV-1 encephalitis. Neuropath Appl Neurobiol. 21:1995;518-528.
8. Furth P.A., St Onge L., Boger H., Gruss P., Gossen M., Kistner A., Bujard H., Hennighausen L. Temporal control of gene expression in transgenic mice by a tetracycline-responsive promoter. Proc Natl Acad Sci USA. 91:1994;9302-9306.
9. Gelbard H.A., James H.J., Sharer L.R., Perry S.W., Saito Y., Kazee A.M., Blumberg B.M., Epstein L.G. Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy. Neuropath Appl Neurobiol. 21:1995;208-217.
10. Hiesiger E.M., Voorhies R.M., Basler G.A., Lipschutz L.E., Posner J.B., Shapiro W.R. Opening the blood-brain and blood-tumor barriers in experimental rat brain tumors: the effect of intracarotid hyperosmolar mannitol on capillary permeability and blood flow. Ann Neurol. 19:1986;50-59.
11. Hopkin K. Glowing mice illuminate gene expression patterns. J NIH Res. 9(June):1997;41-42.
12. Langridge W., Escher A., Wang G., Ayre B., Fodor I., Szalay A. Low-light image analysis of transgenic organisms using bacterial luciferase as a marker. J Bioluminesc Chemiluminesc. 9:1994;185-200.
13. Lassmann H. Inflammation and the blood-brain barrier. Brain Pathol. 1:1991;88.
14. Mayerhofer R., Araki K., Szalay A.A. Monitoring of spatial expression of firefly luciferase in transformed zebrafish. J Bioluminesc Chemiluminesc. 10:1995;271-275.
15. Neuwelt E.A., Weissleder R., Nilaver G., Kroll R.A., Roman-Goldstein S., Szumowski J., Pagel M.A., Jones R.S., Remsen L.G., McCormick C.I.et al. Delivery of virus-sized iron oxide particles to rodent CNS neurons. Neurosurgery. 34:1994;777-784.
16. Power C., Kong P.A., Crawford T.O., Wesselingh S., Glass J.D., McArthur J.C., Trapp B.D. Cerebral white matter changes in acquired immunodeficiency syndrome dementia: alterations of the blood-brain barrier. Ann Neurol. 34:1993;339-350.
17. Rapoport S.I., Hori M., Klatzo I. Reversible osmotic opening of the blood-brain barrier. Science. 173:1971;1026-1028.
18. Rapoport S.I., Fredericks W.R., Ohno K., Pettigrew K.D. Quantitative aspects of reversible osmotic opening of the blood-brain barrier. Am J Physiol. 238:1980;R421-431.
19. Selmaj K. Pathophysiology of the blood-brain barrier. Springer Semin Immunopathol. 18:1996;57-73.
20. Spellerberg B., Prasad S., Cabellos C., Burroughs M., Cahill P., Tuomanen E. Penetration of the blood-brain barrier: enhancement of drug delivery and imaging by bacterial glycopeptides. J Exp Med. 182:1995;1037-1043.
21. Staddon J.M., Rubin L.L. Cell adhesion, cell junctions and the blood-brain barrier. Curr Opin Neurobiol. 6:1996;622-627.
22. Sterrett P.R., Thompson A.M., Chapman A.L., Matzke H.A. The effects of hyperosmolarity on the blood-brain barrier. A morphological and physiological correlation. Brain Res. 77:1974;281-295.
23. Studer R.K., Welch D.M., Siegel B.A. Transient alteration of the blood-brain barrier: effect of hypertonic solutions administered via carotid artery injection. Exp Neurol. 44:1974;266-273.
24. Suzuki M., Iwasaki Y., Yamamoto T., Konno H., Kudo H. Sequelae of the osmotic blood-brain barrier opening in rats. J Neurosurg. 69:1988;421-428.
25. Taubes G. Firefly gene lights up lab animals from inside out. Science. 276:1997;1993.
26. Tuomanen E.I., Prasad S.M., George J.S., Hoepelman A.I., Ibsen P., Heron I., Starzyk R.M. Reversible opening of the blood-brain barrier by anti-bacterial antibodies. Proc Natl Acad Sci USA. 90:1993;7824-7828.
27. Wood K.V., Lam Y.A., McElroy W.D. Introduction to beetle luciferases and their applications. J Bioluminesc Chemiluminesc. 4:1989;289-301.
28. Zhang L., Hellstrom K.E., Chen L. Luciferase activity as a marker of tumor burden and as an indicator of tumor response to antineoplastic therapy in vivo. Clin Exp Metastasis. 12:1994;87-92.